These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33977759)

  • 21. Clinical presentation and follow-up of women affected by Brugada syndrome.
    Berthome P; Tixier R; Briand J; Geoffroy O; Babuty D; Mansourati J; Jesel L; Dupuis JM; Bru P; Kyndt F; Guyomarch B; Thollet A; Behar N; Mabo P; Sacher F; Probst V; Gourraud JB
    Heart Rhythm; 2019 Feb; 16(2):260-267. PubMed ID: 30193851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel prediction model for risk stratification in patients with a type 1 Brugada ECG pattern.
    Subramanian M; Prabhu MA; Rai M; Harikrishnan MS; Sekhar S; Pai PG; Natarajan KU
    J Electrocardiol; 2019; 55():65-71. PubMed ID: 31082614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification of ventricular fibrillation in Brugada syndrome using noninvasive scoring methods.
    Kawazoe H; Nakano Y; Ochi H; Takagi M; Hayashi Y; Uchimura Y; Tokuyama T; Watanabe Y; Matsumura H; Tomomori S; Sairaku A; Suenari K; Awazu A; Miwa Y; Soejima K; Chayama K; Kihara Y
    Heart Rhythm; 2016 Oct; 13(10):1947-54. PubMed ID: 27424075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach.
    Letsas KP; Bazoukis G; Efremidis M; Georgopoulos S; Korantzopoulos P; Fragakis N; Asvestas D; Vlachos K; Saplaouras A; Sakellaropoulou A; Mililis P; Strempelas P; Giannopoulos G; Gavrielatos G; Tzeis S; Kardamis C; Katsivas A; Deftereos S; Stavrakis S; Sideris A
    Europace; 2019 Dec; 21(12):1911-1918. PubMed ID: 31638693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
    Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Ventricular Arrhythmias and Sudden Death in a Québec Cohort With Brugada Syndrome.
    Rivard L; Roux A; Nault I; Champagne J; Roux JF; Tadros R; Talajic M; Cadrin-Tourigny J; Shohoudi A; Mondésert B; Roy D; Macle L; Andrade J; Dyrda K; Dubuc M; Guerra PG; Sarrazin JF; Thibault B; Khairy P
    Can J Cardiol; 2016 Nov; 32(11):1355.e1-1355.e7. PubMed ID: 27378596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome.
    Castro Hevia J; Dorantes Sanchez M; Martinez Lopez F; Castañeda Chirino O; Falcon Rodriguez R; Puga Bravo M; de Zayas Galguera J; Antzelevitch C
    Int J Cardiol; 2019 Feb; 277():130-135. PubMed ID: 30195842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged QRS duration in lead V2 and risk of life-threatening ventricular Arrhythmia in patients with Brugada syndrome.
    Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Nagashima K; Kofune T; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2011; 52(2):98-102. PubMed ID: 21483168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tpeak-Tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome.
    Zumhagen S; Zeidler EM; Stallmeyer B; Ernsting M; Eckardt L; Schulze-Bahr E
    Europace; 2016 Dec; 18(12):1866-1872. PubMed ID: 26941339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel CineECG Derived From Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients With Brugada Syndrome.
    van Dam PM; Locati ET; Ciconte G; Borrelli V; Heilbron F; Santinelli V; Vicedomini G; Monasky MM; Micaglio E; Giannelli L; Mecarocci V; Ćalović Ž; Anastasia L; Pappone C
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008524. PubMed ID: 32755392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brugada syndrome: insights of ST elevation, arrhythmogenicity, and risk stratification from experimental observations.
    Morita H; Zipes DP; Wu J
    Heart Rhythm; 2009 Nov; 6(11 Suppl):S34-43. PubMed ID: 19880072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Trends in Newly Diagnosed Brugada Syndrome: Implications for Risk Stratification.
    Casado-Arroyo R; Berne P; Rao JY; Rodriguez-Mañero M; Levinstein M; Conte G; Sieira J; Namdar M; Ricciardi D; Chierchia GB; de Asmundis C; Pappaert G; La Meir M; Wellens F; Brugada J; Brugada P
    J Am Coll Cardiol; 2016 Aug; 68(6):614-623. PubMed ID: 27491905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brugada Syndrome.
    Krahn AD; Behr ER; Hamilton R; Probst V; Laksman Z; Han HC
    JACC Clin Electrophysiol; 2022 Mar; 8(3):386-405. PubMed ID: 35331438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More than 30 years of Brugada syndrome: a critical appraisal of achievements and open issues.
    Eckardt L; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2024 Mar; 35(1):9-18. PubMed ID: 38085327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Worse Prognosis in Brugada Syndrome Patients With Arrhythmogenic Cardiomyopathy Features.
    Scheirlynck E; Chivulescu M; Lie ØH; Motoc A; Koulalis J; de Asmundis C; Sieira J; Chierchia GB; Brugada P; Cosyns B; Edvardsen T; Droogmans S; Haugaa KH
    JACC Clin Electrophysiol; 2020 Oct; 6(11):1353-1363. PubMed ID: 33121663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low risk for arrhythmic events in asymptomatic patients with drug-induced type 1 ECG. Do patients with drug-induced Brugada type ECG have poor prognosis? (Con).
    Nishizaki M; Sakurada H; Yamawake N; Ueda-Tatsumoto A; Hiraoka M
    Circ J; 2010 Nov; 74(11):2464-73. PubMed ID: 20962431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.